Cell-based therapy approved as alternative to standard UCB transplant for hematological malignancies
In addition to showers, flowers and warmer weather, this spring also brought renewed hope for patients with hematological malignancies undergoing stem cell transplants (SCTs) in the form of the approval of Gamida Cell’s Omisirge® (omidubicel). This cell-based therapy...Current state of affairs: An overview of seven Canadian cell therapy companies
Stephie Leung is currently an Associate Scientist at Artisan Biotechnologies. Stephie started her career in cell and gene therapy with GE Healthcare Lifesciences, working at the Centre for Advanced Therapeutic Cell Technologies, a collaboration between CCRM and GE...A bald endeavour: recent discoveries in the balding mechanism and a possible holy grail
Krystal Jacques completed her Master’s degree in the Institute of Medical Science department at the University of Toronto. For her Master’s she studied the embryonic origin of pancreatic stem cells under the supervision of Dr. Derek van der Kooy, where she developed...Bioethics workshop tackles key questions on clinical translation
Kevin Robb is a PhD candidate in Biomedical Engineering at the University of Toronto and University Health Network. His research is on the development of immunomodulatory cell-based therapies for osteoarthritis. Kevin holds a Bachelor of Science, Honours Physiology...
Comments